Sphingosine Kinase 2 Controls the Aggressive Phenotype of Oral Squamous Cell Carcinoma by Regulating miR-205 and...

Area of Science:

• Oncology
• Molecular Biology
• Biochemistry

Background:

• Head and neck squamous cell carcinoma (HNSCC) involves alterations in microRNAs (miRNAs), p53, and sphingolipid metabolism.
• The specific role of sphingosine kinase (SK)-2 in HNSCC pathogenesis remains unclear.
• Understanding SK2 and p53 interactions is crucial for HNSCC research.

Purpose of the Study:

• To investigate the interplay between SK2 and p53 in regulating specific miRNAs (miR-205 and miR-296) in HNSCC.
• To elucidate the impact of SK2 and p53 on miRNA biogenesis and expression profiles.
• To assess the therapeutic potential of targeting SK2-p53-miRNA pathways in HNSCC.

Main Methods:

• Small-RNA sequencing analysis of oral keratinocytes with altered SK2 and p53 expression.
• Western blot analysis to assess protein levels involved in miRNA biogenesis.
• In vitro functional assays using miRNA mimics and inhibitors in oral keratinocytes and carcinoma cells.
• In vivo studies evaluating tumor formation and growth in mouse models.

Main Results:

• SK2 overexpression altered the expression of over 100 miRNAs, with approximately half regulated by p53.
• miR-205 was downregulated and miR-296 was upregulated in SK2-overexpressing cells, with an inverse correlation observed when p53 was overexpressed.
• Modulating miR-205 and miR-296 levels affected cancer stem-like cell populations and tumor-formation capacity in vitro and in vivo.

Conclusions:

• A significant crosstalk exists between SK2 and p53 in regulating miR-205 and miR-296.
• These miRNAs play a role in HNSCC aggressiveness and cancer stem cell characteristics.
• The SK2-p53-miRNA axis represents a promising avenue for novel HNSCC therapeutic strategies.